Oregon Governor Tina Kotek (D) announced her state has secured a new supply of the abortion pill mifepristone to last nearly through the entirety of the second Trump administration.
In the announcement, Kotek’s office directly cited the “national results of the general election” as to why the Oregon Health Authority (OHA) and Oregon Health & Science University (OHSU) updated their agreement to provide emergency mifepristone.
Kotek in 2023 ordered the OHA to secure a three-year supply of mifepristone through a partnership with OSHU. That supply is set to expire next year in September. The new supply has an expiration of September 2028.
“I believe in reproductive freedom and am committed to being a fierce advocate for every person’s access to safe reproductive health care services, no matter the national landscape,” Kotek said in a statement.
“Oregon is not immune from federal attacks on our reproductive rights. In our state, patients will continue to access the medication they need and providers will deliver these critical services without fear or harassment.”
While President-elect Trump has stated he will leave abortion as a states issue, vowing not to issue a national abortion ban, anxieties over how his second term will affect access to reproductive healthcare have risen.
Orders for the morning-after pill as well as the abortion pills mifepristone and misoprostol spiked following the outcome of the 2024 presidential election. And anti-abortion groups are already planning for ways to circumvent state laws that have enshrined abortion access, including going after the abortion pill.
